SCHEMBL25666341

SCHEMBL25666341

COc1ccc2ccccc2c1-c1ccco1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 2/20 0.66
▸ PLAU P00749 1/20 0.63
▸ KMT2A Q03164 4/20 0.48
▸ MEN1 O00255 3/20 0.48
▸ NISCH Q9Y2I1 1/20 0.48
▸ SMN1; SMN2 Q16637 4/20 0.47
▸ RAB9A P51151 2/20 0.47
▸ ALDH1A1 P00352 2/20 0.47
▸ TP53 P04637 3/20 0.44
▸ NPC1 O15118 1/20 0.44
▸ MAPK1 P28482 2/20 0.43
▸ NFKB1 P19838 1/20 0.43
▸ NFKB2 Q00653 1/20 0.43
▸ RELA Q04206 1/20 0.43
▸ KDM4E B2RXH2 2/20 0.42
▸ HPGD P15428 1/20 0.42
▸ NQO1 P15559 1/20 0.42
▸ ESR1 P03372 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ HTT P42858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26259632 0.84 PLAU (0.58) MAPTPLAUKMT2AMEN1SMN1; SMN2
SCHEMBL26259327 0.82 PLAU (0.57) MAPTPLAUKMT2AMEN1SMN1; SMN2
SCHEMBL25666398 0.82 PLAU (0.57) MAPTPLAUKMT2AMEN1SMN1; SMN2
SCHEMBL998182 0.80 MAPT (1.00) MAPTKMT2AMEN1NISCHSMN1; SMN2
SCHEMBL29428410 0.80 MAPT (1.00) MAPTKMT2AMEN1NISCHSMN1; SMN2
SCHEMBL25667075 0.79 PLAU (0.51) MAPTPLAUKMT2AMEN1SMN1; SMN2
SCHEMBL7338518 0.79 PLAU (0.60) MAPTPLAUKMT2AMEN1SMN1; SMN2
SCHEMBL14134249 0.78 TSHR (0.47) MAPTPLAUKMT2AMEN1SMN1; SMN2
SCHEMBL26259455 0.77 PLAU (0.49) MAPTPLAUKMT2AMEN1SMN1; SMN2
SCHEMBL31336201 0.75 MAPT (0.88) MAPTKMT2AMEN1NISCHSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230287262-A1 PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2023-09-14 — — US disclosed
EP-4202009-A1 PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND Kyushu University, National University Corporation (JP) 2023-06-28 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230287262-A1 PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND NUDC, CCNL2, SPIN3 MAPT 89/4885PLAU 2979/4885KMT2A 3312/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback